Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer

To describe the results obtained in 25 males with metastatic castration-resistant prostate cancer (MCRPC) treated with abiraterone (AA). A comparative analysis of abiraterone effectiveness and safety between our results and data published in the literature was conducted. Bi-institutional prospective...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Actas urologicas españolas 2014-06, Vol.38 (5), p.339-345
Hauptverfasser:	Beardo-Villar, P, Ledo-Cepero, M J, Gavira-Moreno, R, Soto-Delgado, M, Soto-Villalba, J, Alvarez-Ossorio, J L, Juárez-Soto, A
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Abiraterone Acetate - therapeutic use Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Disease-Free Survival Humans Male Middle Aged Prospective Studies Prostatic Neoplasms, Castration-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!